The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Large Will The Thoracentesis And Paracentesis Market Be By 2030 Compared To Its 2026 Market Size?
The thoracentesis and paracentesis market has demonstrated significant expansion in recent years. It is anticipated to increase from $1.49 billion in 2025 to $1.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The historical development of this market is attributable to the rising prevalence of ascites and pleural effusion, the adoption of conventional thoracentesis and paracentesis procedures, increasing hospital infrastructure, greater awareness of minimally invasive procedures, and the demand for diagnostic and therapeutic procedures.
The thoracentesis and paracentesis market is set to experience substantial expansion over the next few years, with projections indicating it will achieve a valuation of $2.15 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period stems from increasing adoption of ultrasound-guided procedures, the development of advanced thoracentesis and paracentesis kits, integration with digital procedural management, the expansion of ambulatory surgical centers, and investments in patient safety and procedural efficiency. Significant trends influencing the market in this period include the widespread use of ultrasound-guided procedure adoption, the implementation of minimally invasive techniques, point-of-care fluid drainage solutions, enhanced procedural safety measures, and the introduction of procedure-specific therapeutic kits.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Thoracentesis And Paracentesis Market?
The increasing incidence of chronic diseases is projected to boost the growth of the thoracentesis and paracentesis market moving forward. Chronic diseases are enduring medical conditions that persist for extended periods, frequently progress slowly, and typically necessitate ongoing management rather than a definitive cure. The increase in chronic disease prevalence is partly linked to inactive lifestyles, as prolonged sitting and minimal physical activity heighten the risk of developing conditions such as heart disease and diabetes. Thoracentesis and paracentesis aid in chronic disease management through minimally invasive procedures that remove excess fluid from the pleural or abdominal cavities, thereby alleviating symptoms and enhancing patient comfort. They facilitate timely monitoring and intervention for conditions like heart failure, liver disease, and malignancies, which helps reduce complications and improves overall disease management and quality of life. For example, in April 2025, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated that in 2023, approximately 76.4% of U.S. adults (194 million) had at least one chronic condition, with 51.4% (131 million) experiencing multiple chronic conditions. Thus, the growing prevalence of chronic diseases is a key factor propelling the thoracentesis and paracentesis market.
What Are The Different Segment Types In The Thoracentesis And Paracentesis Market Segment Breakdown?
The thoracentesis and paracentesis market covered in this report is segmented –
1) By Procedure Type: Ultrasound-Guided Procedures, Blind Or Conventional Procedures
2) By Product Type: Thoracentesis Kits, Paracentesis Kits, Other Product Types
3) By Indication: Ascites, Pleural Effusion, Empyema, Hemothorax
4) By Application: Diagnostic, Therapeutic
5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Ultrasound-Guided Procedures: Diagnostic Ultrasound Guided Procedure, Therapeutic Ultrasound Guided Procedure, Emergency Ultrasound Guided Procedure
2) By Blind Or Conventional Procedures: Diagnostic Blind Procedure, Therapeutic Blind Procedure, Emergency Blind Procedure
Which Trends Are Guiding The Direction Of The Thoracentesis And Paracentesis Market?
Leading companies within the thoracentesis and paracentesis market are concentrating on creating technologically sophisticated solutions, such as automated fluid drainage. This focus aims to elevate procedural safety, lessen patient discomfort, optimize clinical efficiency, and enable continuous monitoring for improved treatment outcomes. Automated fluid drainage refers to the application of devices or systems designed to automatically manage the extraction of bodily fluids from internal cavities, involving regulation of flow, pressure, and safety to enhance both efficiency and patient comfort. As an illustration, in January 2024, Laborie Medical Technologies Inc., a US-based firm specializing in medical technology, unveiled the RenovarP Centesis System. This system represents a fluid drainage device that expands upon an existing paracentesis pump by incorporating an extended indication for thoracentesis procedures. It also features design improvements to its handle and nest, thereby enhancing the overall user experience for healthcare professionals. The system provides a secure, efficient, and minimally invasive method for draining fluid from the abdomen (paracentesis) and chest (thoracentesis), with the objective of enhancing patient comfort and shortening recovery periods.
Who Are The Well-Known Companies In The Thoracentesis And Paracentesis Market?
Major companies operating in the thoracentesis paracentesis market are Cardinal Health Inc., Medtronic plc, Becton Dickinson Company, Boston Scientific Corporation, Teleflex Incorporated, Cook Medical LLC, Merit Medical Systems Inc., Redax S.p.A., Avanos Medical Inc., Poly Medicure Ltd., Axiom Medical Inc., Angiplast Private Limited, Utah Medical Products Inc., Mermaid Medical A/S, PFM Medical AG, ITL Australia Pty Ltd, ATMOS MedizinTechnik GmbH & Co. KG, Vygon SA, PolyMed Medical Devices Pvt. Ltd., Sterimed Medical Devices Pvt. Ltd., Blue Neem Medical Devices Pvt. Ltd.
Get The Full Thoracentesis And Paracentesis Market Report:
https://www.thebusinessresearchcompany.com/report/thoracentesis-and-paracentesis-market-report
Which Region Accounts For The Largest Portion Of The Thoracentesis And Paracentesis Market?
North America was the largest region in the thoracentesis and paracentesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thoracentesis and paracentesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Thoracentesis And Paracentesis Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Thoracentesis And Paracentesis Market 2026, By The Business Research Company
pruritus therapeutic market report 2026
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report
genomic urine testing market report 2026
https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report
ocular genetic diagnostic market report 2026
https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model